Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
ASCO-GU – prostate cancer PARPS move to the front line
EP Vantage
Sun, 02/20/22 - 11:44 am
Tags:
prostate cancer
,
ASCO-GU
,
PARP inhibitors
,
Lynparza
,
Zejula
,
Rubraca
,
Talzenna
,
biomarkers
,
AstraZeneca
,
Merck
,
GSK
,
JNJ
,
Clovis Oncology
Remix Therapeutics signs Janssen licensing deal that could top $1B
Fierce Biotech
Thu, 02/17/22 - 10:53 am
Tags:
Remix Therapeutics
,
RNA
,
Janssen
,
JNJ
,
small molecule drugs
As Johnson & Johnson fights for bankruptcy ploy in talc litigation, Congress is weighing in
Fierce Pharma
Wed, 02/16/22 - 11:07 pm
Tags:
JNJ
,
US Congress
,
legal
,
bankruptcy
AstraZeneca/Merck come out of ASCO GU with a big win over J&J in battle over prostate cancer franchises
Endpoints
Tue, 02/15/22 - 11:31 pm
Tags:
AstraZeneca
,
Merck
,
JNJ
,
ASCO
,
prostate cancer
,
Lynparza
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
Tags:
AC Immune
,
Janssen
,
JNJ
,
vaccines
,
Alzheimer's disease
,
clinical trials
J&J's Blue Jacket Fashion Show returns live to boost prostate cancer awareness
Fierce Pharma
Tue, 02/15/22 - 10:29 am
Tags:
pharma marketing
,
JNJ
,
Janssen
,
oncology
,
prostate cancer
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
Tags:
drug launches
,
Eli Lilly
,
tirzepatide
,
Alnylam
,
vutrisiran
,
Roche
,
Vabysmo
,
JNJ
,
Carvykti
,
Mirati Therapeutics
,
adagrasib
,
Bristol Myers Squibb
,
mavacamten
,
deucravacitinib
Robots cushion omicron's blow to Q4 orthopaedic device sales
Medtech Dive
Wed, 02/9/22 - 10:04 am
Tags:
Medtech
,
devices
,
earnings
,
Zimmer Biomet
,
Stryker
,
JNJ
,
COVID-19
,
robotic surgery
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT
Fierce Pharma
Tue, 02/8/22 - 11:57 pm
Tags:
JNJ
,
vaccines
,
COVID-19
,
RSV
,
drug manufacturing
J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets
Fierce Biotech
Thu, 02/3/22 - 11:18 am
Tags:
JNJ
,
Janssen
,
Mersana
,
antibody-drug conjugate
,
biobucks
J&J Is Hungry for Medical Device M&A
Medical Devices and Diagnostics Industry
Wed, 01/26/22 - 11:05 am
Tags:
JNJ
,
devices
,
Medtech
,
M&A
Go or no go? PDUFA resolutions eyed for J&J and Amryt
EP Vantage
Wed, 01/26/22 - 10:40 am
Tags:
FDA
,
JNJ
,
Legend Biotech
,
ciltacabtagene autoleucel
,
Amryt
,
Oleogel-S10
J&J 'constantly looking' at biotech M&A, but focused on small, mid-sized deals
BioPharma Dive
Tue, 01/25/22 - 11:45 pm
Tags:
JNJ
,
M&A
,
devices
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
CNBC
Tue, 01/25/22 - 11:41 pm
Tags:
JNJ
,
earnings
,
vaccines
,
COVID-19
Nasal sprays to stave off viruses days at a time? J&J’s newest biotech partner draws $140M for 'proactive' approach
Endpoints
Tue, 01/25/22 - 10:58 am
Tags:
intranasal sprays
,
COVID-19
,
JNJ
,
Leyden
COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ
Fierce Pharma
Thu, 01/20/22 - 11:23 pm
Tags:
Pfizer
,
Moderna Therapeutics
,
JNJ
,
AstraZeneca
,
COVID-19
,
vaccines
,
reputation
Will Johnson & Johnson Be a Better Buy After Spinning Off Its Consumer Business?
Motley Fool
Thu, 01/20/22 - 11:02 am
Tags:
JNJ
,
spinoffs
,
consumer health
J&J’s investment arm joins $150M investment in digital health firm Verana
MedCity News
Mon, 01/17/22 - 10:15 am
Tags:
JNJ
,
Verana Health
,
digital health
,
VeraQ
FDA adds rare bleeding risk to J&J shot side effects
Beckers Hospital Review
Thu, 01/13/22 - 07:26 am
Tags:
FDA
,
vaccines
,
JNJ
,
chronic immune thrombocytopenia
,
COVID-19
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
Tags:
JPMHC 2022
,
Bausch Health
,
Amgen
,
Eli Lilly
,
Perrigo
,
JNJ
,
Legend Biotech
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.